OpGen Inc is part of the diagnostic and research industry. The company is engaged in developing molecular information solutions to combat infectious diseases in global healthcare settings. It helps to guide clinicians with information about life-threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. OpGen is working to deliver its molecular information solution to a global network of customers and partners. The company's high-resolution DNA tests are marketed under the Acuitas trade name.